CD79A and cancer: No changes in the avidity of anti-TF IgG (P=0.604) and IgM (P=0.67) were found in cancer patients unlike controls, while the IgA Abs exhibited significantly higher avidity index values (P=0.0109) especially at the earlier stages of the disease ((1-3 a; P=0.0007) (Figure 5).